GSK plc Files 6-K on Share Transactions
Ticker: GLAXF · Form: 6-K · Filed: Sep 15, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Sep 15, 2025 |
| Risk Level | low |
| Pages | 8 |
| Reading Time | 10 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-transactions, 6-K, foreign-private-issuer
TL;DR
GSK plc filed a 6-K on 9/15/25 detailing share transactions for September 2025.
AI Summary
GSK plc filed a Form 6-K on September 15, 2025, reporting transactions in its own shares. The filing is for the month of September 2025 and indicates that GSK plc, formerly GlaxoSmithKline PLC, is a foreign private issuer filing under the 1934 Act. The company's principal executive office is located at 79 New Oxford Street, London, WC1A 1DG.
Why It Matters
This filing provides transparency on GSK's activities related to its own stock, which can be relevant for investors monitoring share buybacks or issuances.
Risk Assessment
Risk Level: low — This is a routine filing reporting on share transactions, not indicating any new material risks.
Key Players & Entities
- GSK plc (company) — Registrant
- GlaxoSmithKline PLC (company) — Former company name
- 79 New Oxford Street, London, WC1A 1DG (location) — Principal executive office address
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
What period does this report cover?
The report covers transactions for the month of September 2025.
What is the company's principal executive office address?
The principal executive office is located at 79 New Oxford Street, London, WC1A 1DG.
Has the company changed its name previously?
Yes, the company was formerly known as GlaxoSmithKline PLC, with a name change date of January 5, 2001.
Does GSK plc file annual reports under Form 20-F or 40-F?
GSK plc files annual reports under cover of Form 20-F.
Filing Stats: 2,531 words · 10 min read · ~8 pages · Grade level 2.1 · Accepted 2025-09-15 08:53:21
Filing Documents
- a2251z.htm (6-K) — 4676KB
- 0001654954-25-010739.txt ( ) — 4677KB
From the Filing
IN OWN SHARES a2251z UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934       For the month of September 2025   Commission File Number 001-15170     GSK plc (Translation of registrant's name into English)     79 New Oxford Street, London, WC1A 1DG (Address of principal executive office)       Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.   Form 20-F . . . .X. . . . Form 40-F . . . . . . . .                                       Transaction in own shares   GSK plc (the " Company ") announces today   acting through its corporate stockbroker, Merrill Lynch International (the " Broker "), it has purchased the following number of the Company's ordinary shares of  31¼  pence each.     Date of purchase: 12 September 2025 Aggregate number of ordinary shares of  31¼  pence each purchased: 203,447 Lowest price paid per share (GBp): 1,502.50p Highest price paid per share (GBp): 1,531.00p Volume-weighted average price paid per share (GBp): 1,512.69p   The purchased shares will be held as Treasury shares.   Such purchase forms part of the Company's existing buyback programme and was effected pursuant to the non-discretionary agreement entered into with the Broker on 4 June 2025, as announced on 4 June 2025. Since 4 June 2025 the Company has purchased 28,641,009 ordinary shares.   Following the above purchase, the Company will hold 246,775,392 ordinary shares in treasury and have 4,068,627,576 ordinary shares in issue (excluding Treasury shares).   The total number of voting rights in the Company is   4,068,627,576. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.   The Company confirms that, in accordance with DTR 5.5.1R, following the above purchase the percentage of voting rights attributable to the ordinary shares held in treasury is   6.07 per cent.   The table below contains detailed information of the individual trades made by the Broker on the London Stock Exchange and the CBOE Europe Limited recognised investment exchange (through its order books having market identification codes CHIX or BATE) as part of the buyback programme.     Schedule of Purchases   Shares purchased:      GSK plc (ISIN: GB00BN7SWP63)   Date of purchases:     12 September 2025   Investment firm:        Merrill Lynch International       Aggregated information per trading venue:   Venue Number of ordinary shares purchased Highest price paid (per ordinary share) (GBp) Lowest price paid (per ordinary share) (GBp) Volume weighted average price paid (per ordinary share) (GBp) London Stock Exchange (XLON) 203,447 1,531.00p 1,502.50p 1,512.69p CBOE (CHIX) 0 - - - CBOE (BATE) 0 - - -     Individual transactions:   Number of Shares Price per Share (GBp) Trading venue Date of transaction Time of transaction Transaction reference number 3 1,517.00  XLON 12-Sep-2025 08:00:44 0XL0640000000000DDPC8F 4 1,517.00  XLON 12-Sep-2025 08:00:44 0XL0640000000000DDPC8G 4 1,517.00  XLON 12-Sep-2025 08:00:44 0XL06D0000000000DDPCBQ 11 1,517.00  XLON 12-Sep-2025 08:00:44 0XL0670000000000DDPC78 12 1,517.00  XLON 12-Sep-2025 08:00:44 0XL0617000000000DDPCC8 12 1,517.00  XLON 12-Sep-2025 08:00:44 0XL06D0000000000DDPCBP 12 1,517.00  XLON 12-Sep-2025 08:00:44 0XL06D0000000000DDPCBR 13 1,517.00  XLON 12-Sep-2025 08:00:44 0XL0610000000000DDPC2Q 13 1,517.00  XLON 12-Sep-2025 08:00:44 0XL0611000000000DDPCA6 13 1,517.00  XLON 12-Sep-2025 08:00:44 0XL0617000000000DDPCC5 13 1,517.00  XLON 12-Sep-2025 08:00:44 0XL0617000000000DDPCC6 13 1,517.00  XLON 12-Sep-2025 08:00:44 0XL0617000000000DDPCC7 13 1,517.00  XLON 12-Sep-2025 08:00:44 0XL06A0000000000DDPC96 14 1,517.00  XLON 12-Sep-2025 08:00:44 0XL06D0000000000DDPCBO 23 1,516.50  XLON 12-Sep-2025